|1.||Thirugnanasambantham, K: 3 articles (10/2014 - 06/2014)|
|2.||Saravanan, S: 3 articles (10/2014 - 06/2014)|
|3.||Ignacimuthu, S: 3 articles (10/2014 - 06/2014)|
|4.||Pandikumar, P: 2 articles (10/2014 - 06/2014)|
|5.||Paulraj, M Gabriel: 2 articles (06/2014 - 06/2014)|
|6.||Islam, V I Hairul: 2 articles (06/2014 - 06/2014)|
|7.||Badami, Shrishailappa: 2 articles (07/2010 - 01/2009)|
|8.||Jaishree, V: 2 articles (07/2010 - 03/2009)|
|9.||Padh, Harish: 2 articles (07/2010 - 10/2009)|
|10.||Rajani, Mandapati: 2 articles (07/2010 - 10/2009)|
|2.||Body Weight (Weight, Body)
07/06/2010 - "Swertiamarin isolated from Enicostemma axillare possesses significant antioxidant and hepatoprotective properties against d-GalN induced hepatotoxicity given at 100 and 200mg/kg body weight orally for 8 days, which might be due to its in vitro antioxidant activity."
07/06/2010 - "The treatment with swertiamarin at 100 and 200mg/kg body weight when administered orally for 8 days prior to d-GalN caused a significant restoration of all the altered biochemical parameters due to d-GalN towards the normal, indicating the potent antioxidant and hepatoprotective nature of swertiamarin. "
06/02/2014 - "The administration of swertiamarin (2, 5, 10mg/kg bw) significantly (P⩽0.05) inhibited the levels of paw thickness, lysosomal enzymes and increased the body weight of experimental animals in a dose dependent manner. "
07/06/2010 - "The hepatoprotective and antioxidant activity of swertiamarin (100 and 200mg/kg body weight) was carried out against d-Galactosamine (d-GalN) (200mg/kg body weight intraperitoneally i.p.) induced liver injury in rats. "
06/01/2015 - "Our study results showed that oral administration of swertiamarin at a dosage of 15, 25, 50 mg/kg bw for 28 days resulted in a significant (p < 0.01) decrease in fasting blood glucose, HbA1c, TC, TG, LDL, and increased the levels of hemoglobin, plasma insulin, TP, body weight, and HDL levels significantly (p < 0.01) when compared to STZ-induced diabetic rats, as confirmed by immunohistochemical studies. "
06/02/2014 - "In the present study, the effect of swertiamarin was evlauated in experimental adjuvant arthritis animal model by the estimation of biochemical (paw thickness, lysosomal enzymes, and urinary degradative products) parameters, proinflammatory cytokines and enzymes along with histopathological and radiographic observations. "
01/01/2012 - "Overall, the data suggest that swertiamarin produced beneficial effects with respect to diabetes-induced cardiovascular complications such as atherosclerosis and nephropathy. "
10/01/2009 - "Overall swertiamarin is an effective lipid-lowering lead compound and can be useful for preventing atherosclerosis."
|5.||Blood Glucose (Blood Sugar)
|7.||Peroxisome Proliferator-Activated Receptors (PPAR)
|9.||Transcription Factors (Transcription Factor)
|10.||Histamine (Histamine Dihydrochloride)